The company is supposed to deliver an update on their cancer vaccine P3 trial before the summer. If the news is good IMO the stock should at a minimum trade into the teens.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.